<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13762">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02927756</url>
  </required_header>
  <id_info>
    <org_study_id>FLT-Oss-2015</org_study_id>
    <nct_id>NCT02927756</nct_id>
  </id_info>
  <brief_title>Italian Multicenter Retrospective Observational Study on Transformed Lymphomas</brief_title>
  <acronym>FLT-Oss-2015</acronym>
  <official_title>Italian Multicenter Retrospective Observational Study on Transformed Lymphomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Città della Salute e della Scienza di Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Città della Salute e della Scienza di Torino</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study purpose is to evaluate treatment outcome and survival in patient with aggressive
      lymphomas transformed from Follicular Lymphoma.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progression Free Survival</measure>
    <time_frame>From first response to last follow-up for at least 2 years (up to 15 years)</time_frame>
    <description>Time from last response to nearest relapse or follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>Date of last follow-up for at least 2 years (up to 15 years)</time_frame>
    <description>Time to last follow-up or death</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Non-Hodgkin Lymphoma Transformed Recurrent</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient with histologically confirmed diagnosis of Transformed Follicular Lymphoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed transformed Follicular Lymphoma

          -  Age &gt; 18 years

          -  Histological transformation between January 2002 and December 2014

          -  Availability of data about treatment and outcome

        Exclusion Criteria:

          -  Other lymphoma diagnosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Botto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOU Città della Salute e della Scienza di Torino</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Botto, MD</last_name>
    <phone>+390116334553</phone>
    <email>bbotto@cittadellasalute.to.it</email>
  </overall_contact>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 6, 2016</lastchanged_date>
  <firstreceived_date>September 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Città della Salute e della Scienza di Torino</investigator_affiliation>
    <investigator_full_name>Barbara Botto</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Non-Hodgkin Lymphoma Transformed Recurrent</keyword>
  <keyword>Discordant Lymphomas</keyword>
  <keyword>Composite Lymphomas</keyword>
  <keyword>Follicular Lymphoma</keyword>
  <keyword>Aggressive Lymphoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>paper publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
